Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane R C, Thibault J, Theoharides T C
Immunology Division, University of Chieti School of Medicine, Italy.
Int Immunol. 1997 Oct;9(10):1563-70. doi: 10.1093/intimm/9.10.1563.
Chemokines may control mast cell infiltrates found in many inflammatory diseases. These cells act through at least two main functions: migration and degranulation. Here we show that human recombinant monocyte chemotactic protein (MCP)-1 (10 ng/50 microliters) induces, after 4 h, an inflammatory vascular permeability and cellular extravasation reaction, determined by Evan's blue dye (1% in saline) injected into the tail vein of the rat, when injected intradermally in the rat skin. The blue color accumulating at the sites of injection provides evidence of vascular permeability and cellular extravasation. The colored areas of the skin were then enucleated and immersed in a fixative solution. Slides were prepared with sections of tissue colored with toluldine blue and analyzed under an optical microscope. A significant number of basophilic cells migrated to the injected area where MCP-1 (10 ng/50 microliters) was used compared to the control PBS treatment. Cell recruitment was slightly less than N-formyl-methionine-leucyl-phenylalanine (used at 10(-6) M/50 microliters). Electron microscopy studies confirmed the presence of basophilic granular cells where MCP-1 was intradermally injected. After preparation of a histidine decarboxylase (HDC) probe, a Northern blot analysis was determined for HDC mRNA in the enucleated tissue injected with MCP-1 (10 ng/50 microliters). Steady-state levels of HDC mRNA levels were induced after 4 h. These results were confirmed by the higher amount of histamine release, compared to the control PBS, in the enucleated tissue from the MCP-1 injection sites. Our results suggest that MCP-1 could play a significant role in diseases characterized by basophilic cell accumulation and migration to sites of tissue damage. Moreover, we show for the first time that MCP-1 is a pro-inflammatory chemokine that induces basophilic cell migration in rat skin injection sites.
趋化因子可能控制着在许多炎症性疾病中发现的肥大细胞浸润。这些细胞至少通过两种主要功能发挥作用:迁移和脱颗粒。在此我们表明,当在大鼠皮肤内注射人重组单核细胞趋化蛋白(MCP)-1(10纳克/50微升)4小时后,通过将伊文思蓝染料(1%溶于生理盐水)注入大鼠尾静脉,可诱导炎症性血管通透性和细胞外渗反应。注射部位积累的蓝色表明了血管通透性和细胞外渗。然后将皮肤的着色区域摘除并浸入固定液中。用甲苯胺蓝染色的组织切片制备玻片,并在光学显微镜下分析。与对照PBS处理相比,在使用MCP-1(10纳克/50微升)的注射区域有大量嗜碱性细胞迁移。细胞募集略少于N-甲酰甲硫氨酰亮氨酰苯丙氨酸(使用浓度为10^(-6)摩尔/50微升)。电子显微镜研究证实了在皮内注射MCP-1的部位存在嗜碱性粒细胞。制备组氨酸脱羧酶(HDC)探针后,对注射MCP-1(10纳克/50微升)的摘除组织中的HDC mRNA进行了Northern印迹分析。4小时后诱导了HDC mRNA水平的稳态。与对照PBS相比,MCP-1注射部位摘除组织中组胺释放量更高,证实了这些结果。我们的结果表明,MCP-1可能在以嗜碱性细胞积累和迁移到组织损伤部位为特征的疾病中发挥重要作用。此外,我们首次表明MCP-1是一种促炎性趋化因子,可诱导大鼠皮肤注射部位的嗜碱性细胞迁移。